首页> 外文期刊>Medical Gas Research >The H2S-releasing naproxen derivative, ATB-346, inhibits alveolar bone loss and inflammation in rats with ligature-induced periodontitis
【24h】

The H2S-releasing naproxen derivative, ATB-346, inhibits alveolar bone loss and inflammation in rats with ligature-induced periodontitis

机译:释放H2S的萘普生衍生物ATB-346抑制结扎诱导的牙周炎大鼠的牙槽骨丢失和炎症

获取原文
获取原文并翻译 | 示例
           

摘要

Background In experimental periodontitis, non-steroidal antiinflammatory drugs (NSAIDs) effectively inhibit the resultant alveolar bone loss. However, their deleterious gastric effects, observed in both animals and humans, dramatically limit their long-term use. It has been proven that the addition of a hydrogen sulfide (H2S)-releasing moiety to classical NSAID structures results in antiinflammatory compounds with improved gastric safeness. In this way, we decided to compare the effects of naproxen with its H2S-releasing derivative ATB-346 on ligature-induced periodontitis in rats.
机译:背景技术在实验性牙周炎中,非甾体类抗炎药(NSAIDs)可有效抑制牙槽骨丢失。然而,在动物和人类中都观察到它们的有害胃作用极大地限制了它们的长期使用。业已证明,向经典的NSAID结构中添加释放硫化氢(H2S)的部分会产生具有改善的胃安全性的抗炎化合物。通过这种方式,我们决定比较萘普生及其释放H2S的衍生物ATB-346对结扎诱发的大鼠牙周炎的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号